Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Discovery
Sponsor : AbCellera
Deal Size : Undisclosed
Deal Type : Acquisition
Details : Integrating TetraGenetics’ capabilities into AbCellera’s technology provides an optimized protein source for AbCellera’s antibody discovery. Together, these technologies have the potential to unlock the discovery of antibodies against validated and...
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
September 13, 2021
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Discovery
Sponsor : AbCellera
Deal Size : Undisclosed
Deal Type : Acquisition